Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 12.50
+0.05 (0.40%)
Oct 27, 2026, 11:42 AM CET
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €212.6 million as of October 26, 2026. It is the 19,605th most valuable company in the world and the 108th biggest in Spain. Its market cap has decreased by 7.79% in one year.
Market Cap
212.60M
Enterprise Value
206.60M
Revenue
250.65M
Global Rank
Country Rank
#108 Spain
PE Ratio
16.32
ChartMarket Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 212.60M, an increase of 2,732.33%. That is a compound annual growth rate of 12.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 212.60M | -5.35% |
| Dec 31, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.38B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Faes Farma | 1.46B |
| Clínica Baviera | 849.76M |
| Laboratorio Reig Jofre | 214.22M |
| Oryzon Genomics | 204.91M |
| Atrys Health | 203.05M |